Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
Description Tirzepatide is a research-grade dual incretin agonist supplied in lyophilised form for laboratory use
When in doubt, discard and reconstitute a fresh vial
Read on for a clear and honest answer
US$ 22.30
US$ 28.66
US$ 27.98
US$ 20.62
US$ 25.38
US$ 28.57
US$ 21.58
US$ 24.92
US$ 26.97
